Eleison Pharmaceuticals Inc. (ELSN)

Eleison Pharmaceuticals will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Total Valuation

Market Cap n/a
Enterprise Value n/a

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 1.17
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee $500,000
Profits Per Employee -$2.30M
Employee Count 2
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Average Volume (30 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ELSN had revenue of $1.00 million and -$4.59 million in losses.

Revenue 1.00M
Gross Profit 1.00M
Operating Income -1.47M
Pretax Income -4.59M
Net Income -4.59M
EBIT -3.17M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has $1.83 million in cash and $516,271 in debt, giving a net cash position of $1.31 million.

Cash & Cash Equivalents 1.83M
Total Debt 516,271
Net Cash 1.31M
Net Cash Per Share n/a
Equity / Book Value 440,785
Book Value Per Share n/a
Working Capital 707,950
Full Balance Sheet

Cash Flow

Operating Cash Flow -9.01M
Capital Expenditures n/a
Free Cash Flow -9.01M
FCF Per Share n/a
Full Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -146.78% and -459.09%.

Gross Margin 100.00%
Operating Margin -146.78%
Pretax Margin -459.09%
Profit Margin -459.09%
EBITDA Margin -316.78%
EBIT Margin -316.78%
FCF Margin -901.21%

Dividends & Yields

ELSN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a